PSTV vs ZTS · P/E 0.2, rev $5.8M vs P/E 25, rev $2.47B
Plus Therapeutics Inc (PSTV) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the PSTV and ZTS stock pages for the full models.
Not investment advice.